Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
34465 | 70 | 23.7 | 31% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3186 | 1602 | EXPERIMENTAL LEPROSY//IGA ALPHA 1 ANTITRYPSIN COMPLEX//IGA ALPHA1 ANTITRYPSIN COMPLEX |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IGA ALPHA 1 ANTITRYPSIN COMPLEX | Author keyword | 1 | 50% | 3% | 2 |
2 | IGA ALPHA1 ANTITRYPSIN COMPLEX | Author keyword | 1 | 100% | 3% | 2 |
3 | LOW MOLECULAR WEIGHT IGM | Author keyword | 1 | 100% | 3% | 2 |
4 | IGM POLYMERIZATION | Author keyword | 1 | 40% | 3% | 2 |
5 | NEONATAL CORD BLOOD | Author keyword | 1 | 50% | 1% | 1 |
6 | SERONEGATIVE OLIGOARTHRITIS | Author keyword | 1 | 50% | 1% | 1 |
7 | GEZHOUBA CENT HOSP | Address | 0 | 25% | 1% | 1 |
8 | IMMUNOBLOTTING TECHNIQUE | Author keyword | 0 | 25% | 1% | 1 |
9 | INFECTIVE DISEASE | Author keyword | 0 | 20% | 1% | 1 |
10 | RADIOLOGICAL DETERIORATION | Author keyword | 0 | 20% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MONOMERIC IGM | 2 | 67% | 3% | 2 |
2 | MONOMERIC 7S IGM | 1 | 50% | 1% | 1 |
3 | IGA ALPHA 1 ANTITRYPSIN COMPLEX | 0 | 33% | 1% | 1 |
4 | MOLECULAR WEIGHT IGM | 0 | 20% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
CIRCULATING LOW-MOLECULAR-WEIGHT IGM - A DISEASE MARKER IN AUTOIMMUNE, INFECTIVE, IMMUNODEFICIENT AND B-CELL LYMPHOPROLIFERATIVE DISORDERS | 1992 | 7 | 51 | 39% |
ARE IMMUNE-COMPLEX ASSAYS USEFUL IN EVALUATING DISEASE-ACTIVITY IN RHEUMATOID-ARTHRITIS | 1984 | 2 | 15 | 20% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GEZHOUBA CENT HOSP | 0 | 25% | 1.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000260635 | RHEUMATOID VASCULITIS//RHEUMATOID MYOSITIS//EXTRAARTICULAR MANIFESTATIONS |
2 | 0.0000182299 | ANTIBODY TO HEPATITIS C VIRUS//ANGIONEUROL//ANTIGEN ANTIBODY DOCKING |
3 | 0.0000172560 | C3 AND C4//COMPLEMENT AND INFLAMMATION//LUPUS EXCELLENCE |
4 | 0.0000139924 | MONOSODIUM URATE MONOHYDRATE//MONOSODIUM URATE CRYSTALS//MSU CRYSTALS |
5 | 0.0000139873 | INTRAVENOUS LASER RADIATION OF BLOOD//INTERNAL DIS 3//ACUTE RADIATION DISEASE |
6 | 0.0000139672 | IGG RHEUMATOID FACTOR//IMMUNOGLOBULIN GENES//CROSS REACTIVE IDIOTYPE |
7 | 0.0000133134 | SECRETORY COMPONENT//POLYMERIC IMMUNOGLOBULIN RECEPTOR//FC ALPHA RI |
8 | 0.0000129111 | AVIAN ENCEPHALOMYELITIS//AVIAN ENCEPHALOMYELITIS VIRUS//AVIAN ENCEPHALOMYELITIS VIRUS AEV |
9 | 0.0000116115 | GENOVESI//ARACHNE//CHARLES OF BOURBON |
10 | 0.0000111682 | B 1 CELLS//B1 CELL//CD5 B LYMPHOCYTES |